Yi-Sheng Chang

Dr. Yi-Sheng Chang


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 October 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
YCYi-Sheng Chang
Yi-Sheng Chang
PCPo-Lin Chen
Po-Lin Chen
JHJia-Horung Hung
Jia-Horung Hung
HCHsiao-Yen Chen
Hsiao-Yen Chen
CLChun-Chieh Lai
Chun-Chieh Lai
STSung-Huei Tseng
Sung-Huei Tseng
Paranasal sinusitis is widespread and can lead to orbital complications, blindness, and death. However, the correlation between ophthalmological findings and disease staging remains unclear. This study aimed to investigate the staging, acute ophthalmological manifestations, diagnosis, management, and outcomes of orbital complications of paranasal sinusitis during a 27-year period. We retrospectively reviewed the medical records of all patients with orbital complications of paranasal sinusitis hospitalized at the National Cheng Kung University Hospital, a medical center in Taiwan during 1988–2015. Sex, age, symptoms, history, ophthalmological findings, laboratory and imaging findings, treatments, and outcomes were analyzed by staging. Eighty-three patients aged 9 days to 80 years had stage I (preseptal cellulitis, n = 39 patients), II (postseptal orbital cellulitis, n = 8), III (subperiosteal abscess, n = 16), IV (orbital abscess, n = 8), or V (intracranial involvement, n = 12) complications. Peak incidences occurred in patients aged 0–19 and 60–69 years. Chronic sinusitis and diabetes mellitus were common preexisting diseases. Extraocular movement limitation and proptosis predicted postseptal (stage II or more) involvement. The likelihood of elevated intraocular pressure increased with stage. Reduced visual acuity and presence of relative afferent pupillary defect indicated consideration of magnetic resonance imaging to investigate possible intracranial extension. Ipsilateral maxillary (81.7%) and ethmoidal (75.6%) sinuses were the most common sources of infection, and the most frequently implicated pathogens were coagulase-negative Staphylococcus spp. (25.3%) and Staphylococcus aureus (20.5%). All patients received intravenous antimicrobial therapy (multi-drug therapy in 88.0%), and 55.4% underwent surgery, most commonly endoscopic sinus surgery. One (1.2%) diabetic man with stage V complications died of fungal sinusitis with intracranial invasion. Five (6.0%) patients, all stage V, lost vision despite intensive treatment. The average length of hospital stay was 13.8 days (range 2–72 days), and significantly longer stays were associated with stages II–V as compared to stage I. Orbital infection originating from paranasal sinusitis can cause vision loss and death due to intracranial extension. Acute ophthalmological findings predict staging and prognosis. Cooperative consultation between ophthalmologists, otorhinolaryngologists, and neurologists is essential. Urgent diagnostic studies and aggressive antimicrobial therapy are indicated, and surgery should be considered.

25 February 2022 in Vaccines
Verified
Journal Article
Open access
PDF file
PCPo-Jui Chen
Po-Jui Chen
YCYi-Sheng Chang
Yi-Sheng Chang
CLChen-Chee Lim
Chen-Chee Lim
YLYu Kuei Lee
Yu Kuei Lee
Due to the COVID-19 pandemic, numerous vaccines have been developed for the disease. However, with large-scale vaccination has come the gradual emergence of immunological phenomena caused by these new vaccines. Herein, we report a 48-year-old female with a sudden onset of inferior visual field defects in the left eye following her first dose of the ChAdOx1 vaccine. Dilated fundus examination combined with optical coherence tomography and fluorescein angiography confirmed the diagnosis of branch retinal artery occlusion. Within 4 weeks following vaccination, symptoms associated with hearing impairment developed, and magnetic resonance imaging revealed leptomeningeal enhancement. The diagnosis of Susac syndrome (SS) was confirmed. The development of SS may be caused by endotheliopathy resulting from the molecular mimicry of the ChAdOx1 vaccine. Clinicians should be aware of the symptoms of SS, which may develop after COVID-19 vaccination. Further experimental surveillance and case–control studies are required to confirm this relationship.

4 May 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
YCYi-Sheng Chang
Yi-Sheng Chang
YTYu-Ti Teng
Yu-Ti Teng
YHYi-Hsun Huang
Yi-Hsun Huang
MLMei-Ling Liu
Mei-Ling Liu
JHJia-Horung Hung
Jia-Horung Hung
STSung-Huei Tseng
Sung-Huei Tseng
We investigated the temporal changes in major eye injuries in Taiwan by reviewing the medical records of all patients with ocular trauma hospitalized at the National Cheng Kung University Hospital during 2002–2004 and 2012–2014. A total of 169 eyes (161 patients) during 2002–2004 and 121 eyes (120 patients) during 2012–2014 were enrolled (mean ± SD age: 41.9 ± 20.8 years in 2002–2004, and 51.8 ± 19.3 years in 2012–2014). Males accounted for ~75% of patients. The most frequent injury-causing object was metallic material (~24%), and blunt traumas were most frequently attributable to traffic accidents and falls. The most common locations of injuries for males and females were the workplace and home, respectively. Open-globe injuries occurred in ~70% of eyes, requiring primary repair, cataract extraction, and/or intraocular lens implantation. The frequencies of fall injury, lacrimal system laceration, lens injury, corneal/scleral foreign bodies, and use of intracameral antibiotics increased from 2002–2004 to 2012–2014, while those of closed-globe injury, vitreous haemorrhage, optic nerve injury, and medical treatment decreased. The final visual acuity remained poor (≤20/200) in >1/3 of injured eyes. Despite therapeutic advancements, major eye injuries still pose a high risk for poor visual outcome.

10 May 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
YCYi-Sheng Chang
Yi-Sheng Chang
Wan-Ju Annabelle LeeWan-Ju Annabelle Lee
Wan-Ju Annabelle Lee
CLChen-Chee Lim
Chen-Chee Lim
SWShih-Hao Wang
Shih-Hao Wang
SHSheng-Min Hsu
Sheng-Min Hsu
STSung-Huei Tseng
Sung-Huei Tseng
This study investigated the “real-world” use of ranibizumab for neovascular age-related macular degeneration (nAMD) in Taiwan and assessed the visual outcome. We reviewed the medical records at National Cheng Kung University Hospital, Taiwan, during 2012–2014 for 264 consecutive eyes of 229 patients with nAMD, who applied for ranibizumab covered by national health insurance. A total of 194 eyes (73.5%) in 179 patients (65.5% men; mean ± standard deviation age 69.4 ± 10.7 years) were pre-approved for treatment. Applications for treatment increased year by year, but approval rates decreased during this time. The major causes of rejection for funding were diseases mimicking nAMD, including macular pucker/epiretinal membrane, macular scarring, dry-type AMD, and possible polypoidal choroidal vasculopathy. After completion of three injections in 147 eyes, visual acuity significantly improved, gaining ≥1 line in 51.8% of eyes and stabilising in 38.3% of 141 eyes in which visual acuity was measured. The 114 eyes approved with only one application had a better visual outcome than the 27 eyes approved after the second or third applications. In conclusion, ranibizumab is effective for nAMD; however, approval after the second or third application for national health insurance cover is a less favourable predictor of visual outcome.

11 June 2017 in Canadian Medical Association Journal
Verified
Journal Article
Closed access
JHJia-Horung Hung
Jia-Horung Hung
YCYi-Sheng Chang
Yi-Sheng Chang

5 September 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
YCYi-Sheng Chang
Yi-Sheng Chang
YTYu-Ti Teng
Yu-Ti Teng
YHYi-Hsun Huang
Yi-Hsun Huang
MLMei-Ling Liu
Mei-Ling Liu
JHJia-Horung Hung
Jia-Horung Hung
STSung-Huei Tseng
Sung-Huei Tseng
A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has not been fixed in the paper.